Pulse Biosciences (PLSE – Research Report) received a Hold rating from H.C. Wainwright analyst Swayampakula Ramakanth today. The company's shares closed last Thursday at $1.48, close to its 52-week low of $1.41. According to TipRanks.com, Ramakanth is a 1-star analyst with an average return of -2.4% and a 31.0% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals, Corvus Pharmaceuticals, and Janux Therapeutics Inc. Currently, the analyst consensus on Pulse Biosciences is a Moderate Buy with an average price target of $5.00, representing a 203.0% upside. In a report released yesterday, Stephens also downgraded the stock to Hold with a $5.00 price target.
https://www.tipranks.com/news/blurbs/analyst-explains-why-they-downgraded-their-rating-on-pulse-biosciences-plse?utm_source=advfn.com&utm_medium=referral
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Pulse Biosciences Charts.
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Pulse Biosciences Charts.